• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

造血系统恶性肿瘤亚克隆发生和依赖性的体内模型。

In vivo models of subclonal oncogenesis and dependency in hematopoietic malignancy.

机构信息

Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Cancer Biology, Perelman Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA.

Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Leukemia Service, Department of Medicine and Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

出版信息

Cancer Cell. 2024 Nov 11;42(11):1955-1969.e7. doi: 10.1016/j.ccell.2024.10.009.

DOI:10.1016/j.ccell.2024.10.009
PMID:39532065
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11561369/
Abstract

Cancer evolution is a multifaceted process leading to dysregulation of cellular expansion and differentiation through somatic mutations and epigenetic dysfunction. Clonal expansion and evolution is driven by cell-intrinsic and -extrinsic selective pressures, which can be captured with increasing resolution by single-cell and bulk DNA sequencing. Despite the extensive genomic alterations revealed in profiling studies, there remain limited experimental systems to model and perturb evolutionary processes. Here, we integrate multi-recombinase tools for reversible, sequential mutagenesis from premalignancy to leukemia. We demonstrate that inducible Flt3 mutations differentially cooperate with Dnmt3a, Idh2, and Npm1 mutant alleles, and that changing the order of mutations influences cellular and transcriptional landscapes. We next use a generalizable, reversible approach to demonstrate that mutation reversion results in rapid leukemic regression with distinct differentiation patterns depending upon co-occurring mutations. These studies provide a path to experimentally model sequential mutagenesis, investigate mechanisms of transformation and probe oncogenic dependency in disease evolution.

摘要

癌症进化是一个多方面的过程,通过体细胞突变和表观遗传功能障碍导致细胞扩张和分化失调。克隆扩增和进化是由细胞内在和外在的选择压力驱动的,可以通过单细胞和批量 DNA 测序以越来越高的分辨率来捕获。尽管在分析研究中揭示了广泛的基因组改变,但仍然缺乏用于模拟和干扰进化过程的有限实验系统。在这里,我们整合了多种重组酶工具,用于从癌前病变到白血病的可逆、连续诱变。我们证明,诱导型 Flt3 突变与 Dnmt3a、Idh2 和 Npm1 突变等位基因不同程度地合作,并且突变顺序的改变会影响细胞和转录景观。我们接下来使用一种可推广的、可逆的方法来证明,突变逆转会导致急性白血病迅速消退,并根据共同发生的突变产生不同的分化模式。这些研究为实验模拟连续诱变、研究转化机制以及在疾病进化中探测致癌依赖性提供了一条途径。

相似文献

1
In vivo models of subclonal oncogenesis and dependency in hematopoietic malignancy.造血系统恶性肿瘤亚克隆发生和依赖性的体内模型。
Cancer Cell. 2024 Nov 11;42(11):1955-1969.e7. doi: 10.1016/j.ccell.2024.10.009.
2
Perspectives for therapeutic targeting of gene mutations in acute myeloid leukaemia with normal cytogenetics.正常核型急性髓系白血病基因突变的治疗靶点展望
Br J Haematol. 2015 Aug;170(3):305-22. doi: 10.1111/bjh.13409. Epub 2015 Apr 19.
3
Molecular subtypes of NPM1 mutations have different clinical profiles, specific patterns of accompanying molecular mutations and varying outcomes in intermediate risk acute myeloid leukemia.NPM1突变的分子亚型在中危急性髓系白血病中具有不同的临床特征、伴随分子突变的特定模式及不同的预后。
Haematologica. 2016 Feb;101(2):e55-8. doi: 10.3324/haematol.2015.133819. Epub 2015 Oct 15.
4
DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodeling.DNMT3A突变通过受损的核小体重塑促进急性髓性白血病对蒽环类药物的耐药性。
Nat Med. 2016 Dec;22(12):1488-1495. doi: 10.1038/nm.4210. Epub 2016 Nov 14.
5
[Mutation of isocitrate dehydrogenase 2 (IDH2) gene in Chinese AML patients and its clinical significance].[中国急性髓系白血病患者异柠檬酸脱氢酶2(IDH2)基因突变及其临床意义]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Jun;21(3):607-12. doi: 10.7534/j.issn.1009-2137.2013.03.014.
6
Only FLT3-ITD co-mutation did not have a deleterious effect on acute myeloid leukemia patients with NPM1 mutation, but concomitant with DNMT3A co-mutation or a < 3log reduction of MRD2 predicted poor survival.仅 FLT3-ITD 共突变对伴有 NPM1 突变的急性髓系白血病患者没有不良影响,但伴有 DNMT3A 共突变或 MRD2 减少 < 3log 预示着不良生存。
Ann Hematol. 2024 Nov;103(11):4525-4535. doi: 10.1007/s00277-024-06001-6. Epub 2024 Sep 17.
7
Dnmt3a loss and Idh2 neomorphic mutations mutually potentiate malignant hematopoiesis.DNMT3A 缺失和 IDH2 新突变协同促进恶性造血。
Blood. 2020 Mar 12;135(11):845-856. doi: 10.1182/blood.2019003330.
8
Sequentially inducible mouse models reveal that Npm1 mutation causes malignant transformation of Dnmt3a-mutant clonal hematopoiesis.序贯诱导的小鼠模型揭示 Npm1 突变导致 Dnmt3a 突变克隆性造血的恶性转化。
Leukemia. 2019 Jul;33(7):1635-1649. doi: 10.1038/s41375-018-0368-6. Epub 2019 Jan 28.
9
Rethinking the gold standard for recurrent DNA mutations detection in acute myeloid leukemia.重新思考急性髓系白血病中复发性DNA突变检测的金标准。
Eur J Haematol. 2016 Feb;96(2):109-10. doi: 10.1111/ejh.12604.
10
Molecular evaluation of DNMT3A and IDH1/2 gene mutation: frequency, distribution pattern and associations with additional molecular markers in normal karyotype Indian acute myeloid leukemia patients.DNMT3A和IDH1/2基因突变的分子评估:正常核型印度急性髓系白血病患者的频率、分布模式及与其他分子标志物的关联
Asian Pac J Cancer Prev. 2014;15(3):1247-53. doi: 10.7314/apjcp.2014.15.3.1247.

引用本文的文献

1
IMOP-Cancer: identifying mutation order pairs impacting cancer phenotypes.IMOP-癌症:识别影响癌症表型的突变顺序对。
Brief Bioinform. 2025 Jul 2;26(4). doi: 10.1093/bib/bbaf362.
2
Tumor Heterogeneity and the Immune Response in Non-Small Cell Lung Cancer: Emerging Insights and Implications for Immunotherapy.非小细胞肺癌中的肿瘤异质性与免疫反应:免疫治疗的新见解及意义
Cancers (Basel). 2025 Mar 19;17(6):1027. doi: 10.3390/cancers17061027.
3
Neoadjuvant immunotherapy for dMMR and pMMR colorectal cancers: therapeutic strategies and putative biomarkers of response.

本文引用的文献

1
Cre recombinase expression cooperates with homozygous FLT3 internal tandem duplication knockin mouse model to induce acute myeloid leukemia.Cre 重组酶表达与纯合性 FLT3 内部串联重复 knockin 小鼠模型协同诱导急性髓系白血病。
Leukemia. 2023 Apr;37(4):741-750. doi: 10.1038/s41375-023-01832-0. Epub 2023 Feb 4.
2
Inflammatory exposure drives long-lived impairment of hematopoietic stem cell self-renewal activity and accelerated aging.炎症暴露会导致造血干细胞自我更新活动的长期损伤和加速衰老。
Cell Stem Cell. 2022 Aug 4;29(8):1273-1284.e8. doi: 10.1016/j.stem.2022.06.012. Epub 2022 Jul 19.
3
A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia.
新辅助免疫疗法治疗错配修复缺陷型和微卫星稳定型结直肠癌:治疗策略和可能的反应生物标志物。
Nat Rev Clin Oncol. 2024 Dec;21(12):839-851. doi: 10.1038/s41571-024-00943-6. Epub 2024 Sep 24.
一种用于理解急性髓系白血病异质性和预测药物反应的细胞层次结构框架。
Nat Med. 2022 Jun;28(6):1212-1223. doi: 10.1038/s41591-022-01819-x. Epub 2022 May 26.
4
Lineage tracing reveals the phylodynamics, plasticity, and paths of tumor evolution.谱系追踪揭示了肿瘤进化的系统发育动力学、可塑性和途径。
Cell. 2022 May 26;185(11):1905-1923.e25. doi: 10.1016/j.cell.2022.04.015. Epub 2022 May 5.
5
Stepwise-edited, human melanoma models reveal mutations' effect on tumor and microenvironment.逐步编辑的人类黑色素瘤模型揭示了突变对肿瘤和微环境的影响。
Science. 2022 Apr 29;376(6592):eabi8175. doi: 10.1126/science.abi8175.
6
Non-genetic determinants of malignant clonal fitness at single-cell resolution.单细胞分辨率下恶性克隆适应性的非遗传决定因素。
Nature. 2022 Jan;601(7891):125-131. doi: 10.1038/s41586-021-04206-7. Epub 2021 Dec 8.
7
Deciphering intratumoral heterogeneity using integrated clonal tracking and single-cell transcriptome analyses.利用整合的克隆追踪和单细胞转录组分析破译肿瘤内异质性。
Nat Commun. 2021 Nov 11;12(1):6522. doi: 10.1038/s41467-021-26771-1.
8
Dual recombinase action in the normal and neoplastic mammary gland epithelium.正常和肿瘤乳腺上皮细胞中的双重重组酶作用。
Sci Rep. 2021 Oct 21;11(1):20775. doi: 10.1038/s41598-021-00231-8.
9
Dual Inhibition of FLT3 and AXL by Gilteritinib Overcomes Hematopoietic Niche-Driven Resistance Mechanisms in -ITD Acute Myeloid Leukemia.吉瑞替尼对FLT3和AXL的双重抑制克服了造血微环境驱动的FLT3-ITD急性髓系白血病耐药机制。
Clin Cancer Res. 2021 Nov 1;27(21):6012-6025. doi: 10.1158/1078-0432.CCR-20-3114. Epub 2021 Aug 16.
10
A suite of new Dre recombinase drivers markedly expands the ability to perform intersectional genetic targeting.一套新的 Dre 重组酶驱动明显扩展了进行交叉遗传靶向的能力。
Cell Stem Cell. 2021 Jun 3;28(6):1160-1176.e7. doi: 10.1016/j.stem.2021.01.007. Epub 2021 Feb 9.